Neurogene Stock

neurogene.comHealthcareFounded: 2018Funding to Date: $183.58MM

Neurogene develops life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.

Register for Details

For more details on financing and valuation for Neurogene, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Neurogene.

Register Today

Other companies like Neurogene in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM